Literature DB >> 24780625

Huntingtin protein is essential for mitochondrial metabolism, bioenergetics and structure in murine embryonic stem cells.

Ismail Ismailoglu1, Qiuying Chen2, Melissa Popowski1, Lili Yang2, Steven S Gross3, Ali H Brivanlou4.   

Abstract

Mutations in the Huntington locus (htt) have devastating consequences. Gain-of-poly-Q repeats in Htt protein causes Huntington's disease (HD), while htt(-/-) mutants display early embryonic lethality. Despite its importance, the function of Htt remains elusive. To address this, we compared more than 3700 compounds in three syngeneic mouse embryonic stem cell (mESC) lines: htt(-/-), extended poly-Q (Htt-Q140/7), and wild-type mESCs (Htt-Q7/7) using untargeted metabolite profiling. While Htt-Q140/7 cells did not show major differences in cellular bioenergetics, we find extensive metabolic aberrations in htt(-/-) mESCs, including (i) complete failure of ATP production despite preservation of the mitochondrial membrane potential; (ii) near-maximal glycolysis, with little or no glycolytic reserve; (iii) marked ketogenesis; (iv) depletion of intracellular NTPs; (v) accelerated purine biosynthesis and salvage; and (vi) loss of mitochondrial structural integrity. Together, our findings reveal that Htt is necessary for mitochondrial structure and function from the earliest stages of embryogenesis, providing a molecular explanation for htt(-/-) early embryonic lethality.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AMP kinase; Embryonic stem cells; Glycolysis; Huntington׳s Disease; LC-MS/MS; Metabolism; Metabolomics; Mitochondria; Mitochondrial bioenergetics; Mitochondrial respiration; Oxygen consumption; Untargeted metabolite profiling

Mesh:

Substances:

Year:  2014        PMID: 24780625      PMCID: PMC4109978          DOI: 10.1016/j.ydbio.2014.04.005

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  46 in total

1.  Small-molecule inducers of Aβ-42 peptide production share a common mechanism of action.

Authors:  Karima Bettayeb; Nassima Oumata; Yuanyuan Zhang; Wenjie Luo; Victor Bustos; Hervé Galons; Paul Greengard; Laurent Meijer; Marc Flajolet
Journal:  FASEB J       Date:  2012-09-12       Impact factor: 5.191

2.  HIP1 functions in clathrin-mediated endocytosis through binding to clathrin and adaptor protein 2.

Authors:  M Metzler; V Legendre-Guillemin; L Gan; V Chopra; A Kwok; P S McPherson; M R Hayden
Journal:  J Biol Chem       Date:  2001-08-21       Impact factor: 5.157

3.  Novel PINK1 mutations in early-onset parkinsonism.

Authors:  Yasuko Hatano; Yuanzhe Li; Kenichi Sato; Shuichi Asakawa; Yasuhiro Yamamura; Hiroyuki Tomiyama; Hiroyo Yoshino; Masato Asahina; Susumu Kobayashi; Sharon Hassin-Baer; Chin-Song Lu; Arlene R Ng; Raymond L Rosales; Nobuyoshi Shimizu; Tatsushi Toda; Yoshikuni Mizuno; Nobutaka Hattori
Journal:  Ann Neurol       Date:  2004-09       Impact factor: 10.422

4.  Huntingtin bodies sequester vesicle-associated proteins by a polyproline-dependent interaction.

Authors:  Zheng-Hong Qin; Yumei Wang; Ellen Sapp; Benjamin Cuiffo; Erich Wanker; Michael R Hayden; Kimberly B Kegel; Neil Aronin; Marian DiFiglia
Journal:  J Neurosci       Date:  2004-01-07       Impact factor: 6.167

Review 5.  Wild-type huntingtin plays a role in brain development and neuronal survival.

Authors:  Anton Reiner; Ioannis Dragatsis; Scott Zeitlin; Daniel Goldowitz
Journal:  Mol Neurobiol       Date:  2003-12       Impact factor: 5.590

6.  Differential loss of striatal projection neurons in Huntington disease.

Authors:  A Reiner; R L Albin; K D Anderson; C J D'Amato; J B Penney; A B Young
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

7.  Mutant Huntingtin alters retrograde transport of TrkB receptors in striatal dendrites.

Authors:  Géraldine Liot; Diana Zala; Patrick Pla; Guillaume Mottet; Matthieu Piel; Frédéric Saudou
Journal:  J Neurosci       Date:  2013-04-10       Impact factor: 6.167

8.  Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release.

Authors:  Yeun Su Choo; Gail V W Johnson; Marcy MacDonald; Peter J Detloff; Mathieu Lesort
Journal:  Hum Mol Genet       Date:  2004-05-26       Impact factor: 6.150

9.  Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.

Authors:  C Zuccato; A Ciammola; D Rigamonti; B R Leavitt; D Goffredo; L Conti; M E MacDonald; R M Friedlander; V Silani; M R Hayden; T Timmusk; S Sipione; E Cattaneo
Journal:  Science       Date:  2001-06-14       Impact factor: 47.728

10.  A series of N-terminal epitope tagged Hdh knock-in alleles expressing normal and mutant huntingtin: their application to understanding the effect of increasing the length of normal Huntingtin's polyglutamine stretch on CAG140 mouse model pathogenesis.

Authors:  Shuqiu Zheng; Nima Ghitani; Jessica S Blackburn; Jeh-Ping Liu; Scott O Zeitlin
Journal:  Mol Brain       Date:  2012-08-14       Impact factor: 4.041

View more
  30 in total

Review 1.  Huntington's Disease and Mitochondria.

Authors:  Mohammad Jodeiri Farshbaf; Kamran Ghaedi
Journal:  Neurotox Res       Date:  2017-06-21       Impact factor: 3.911

2.  Rewiring of Glutamine Metabolism Is a Bioenergetic Adaptation of Human Cells with Mitochondrial DNA Mutations.

Authors:  Qiuying Chen; Kathryne Kirk; Yevgeniya I Shurubor; Dazhi Zhao; Andrea J Arreguin; Ifrah Shahi; Federica Valsecchi; Guido Primiano; Elizabeth L Calder; Valerio Carelli; Travis T Denton; M Flint Beal; Steven S Gross; Giovanni Manfredi; Marilena D'Aurelio
Journal:  Cell Metab       Date:  2018-04-12       Impact factor: 27.287

3.  Oxidative metabolism in YAC128 mouse model of Huntington's disease.

Authors:  James Hamilton; Jessica J Pellman; Tatiana Brustovetsky; Robert A Harris; Nickolay Brustovetsky
Journal:  Hum Mol Genet       Date:  2015-06-03       Impact factor: 6.150

4.  Oxidative metabolism and Ca2+ handling in striatal mitochondria from YAC128 mice, a model of Huntington's disease.

Authors:  James Hamilton; Tatiana Brustovetsky; Nickolay Brustovetsky
Journal:  Neurochem Int       Date:  2017-01-03       Impact factor: 3.921

Review 5.  Mitochondrial Abnormalities and Synaptic Damage in Huntington's Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics.

Authors:  Neha Sawant; Hallie Morton; Sudhir Kshirsagar; Arubala P Reddy; P Hemachandra Reddy
Journal:  Mol Neurobiol       Date:  2021-09-14       Impact factor: 5.590

6.  Temporal Characterization of Behavioral and Hippocampal Dysfunction in the YAC128 Mouse Model of Huntington's Disease.

Authors:  Cristine de Paula Nascimento-Castro; Elisa C Winkelmann-Duarte; Gianni Mancini; Priscilla Gomes Welter; Evelini Plácido; Marcelo Farina; Joana Gil-Mohapel; Ana Lúcia S Rodrigues; Andreza Fabro de Bem; Patricia S Brocardo
Journal:  Biomedicines       Date:  2022-06-17

7.  Huntingtin Co-Isolates with Small Extracellular Vesicles from Blood Plasma of TgHD and KI-HD Pig Models of Huntington's Disease and Human Blood Plasma.

Authors:  Hanadi Ananbeh; Jaromir Novak; Stefan Juhas; Jana Juhasova; Jiri Klempir; Kristyna Doleckova; Irena Rysankova; Karolina Turnovcova; Jaroslav Hanus; Hana Hansikova; Petr Vodicka; Helena Kupcova Skalnikova
Journal:  Int J Mol Sci       Date:  2022-05-17       Impact factor: 6.208

Review 8.  Manganese and the Insulin-IGF Signaling Network in Huntington's Disease and Other Neurodegenerative Disorders.

Authors:  Miles R Bryan; Aaron B Bowman
Journal:  Adv Neurobiol       Date:  2017

Review 9.  Metabolomic Applications in Stem Cell Research: a Review.

Authors:  Daniela S C Bispo; Catarina S H Jesus; Inês M C Marques; Katarzyna M Romek; Mariana B Oliveira; João F Mano; Ana M Gil
Journal:  Stem Cell Rev Rep       Date:  2021-06-16       Impact factor: 5.739

Review 10.  Purine Nucleotides Metabolism and Signaling in Huntington's Disease: Search for a Target for Novel Therapies.

Authors:  Marta Tomczyk; Talita Glaser; Ewa M Slominska; Henning Ulrich; Ryszard T Smolenski
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.